The Cannon is expecting to open by the end of next month. Courtesy of The Cannon

If all goes according to plan, The Cannon's new space will be up and running by the end of June. The bulk of the construction, which started a little over a year ago, is done, and the team is on the home stretch.

The original plan was to open in March, but construction faced a series of setbacks due to weather.

"Houston's rainy winter pushed back our initial timeline a bit, but we are currently on track for opening late next month and are excited to get our amazing community moved into our brand new home," says Lawson Gow, founder and CEO of The Cannon. "We can't wait to show off our space to Houston's entrepreneurial community through events, programming, new partnerships and more, continuing in our mission to support Houston's startups and small businesses."

Two Houston-based companies are responsible for the 120,000-square-foot, 32-acre coworking and entrepreneurship campus in West Houston — Burton Construction is the general contractor and Abel Design Group is the architect.

The new space is already 80 percent pre-leased. Currently, The Cannon has a 20,000-square-foot space next door to the construction site. While companies working out of this so-called "waiting room" building will be moving over, Gow, who is the son of InnovationMap's CEO, is excited to announce a few new startups excited to call The Cannon home next month.

The goal of The Cannon's project is to fulfill a need Gow says he recognized in Houston.

"The problem that we're addressing — every startup is addressing a problem — is Houston has really struggled to develop vibrant startup communities," Gow tells InnovationMap in a previous interview. "Entrepreneurs and talent will leave to go to Austin and beyond, and so the mission was to create a place and an infrastructure and a density of resources to prevent them from having to do that and keep our entrepreneurs here."

The new space will allow Gow and his team to host pitch events and even live fundraising events, due to a partnership with LetsLaunch.

Progress

Courtesy of The Cannon

The Cannon's construction delays were mostly due to a rainy season in Houston.

Take a video tour of The Cannon here:

The Cannon Flythroughwww.youtube.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”